Medically reviewed by Kashif J. Piracha, MD Subcutaneous fat is the fat right under your skin—the kind you can pinch. It ...
The FDA cited issues with a manufacturing facility as the reason for the rejection. J&J is currently “working closely” with ...
Johnson & Johnson JNJ announced that the FDA has issued a complete response letter (“CRL”) to its biologics license ...
Tryngolza is once-monthly, subcutaneous RNA-targeted therapy and is expected to be available by the end of the year with a ...
In the continuation of our discussion with Chris Sayed, MD, University of North Carolina at Chapel Hill Department of ...
A PHASE 3 clinical trial, explorer8, has demonstrated the efficacy and safety of concizumab, a monoclonal antibody in ...
Primary results from the phase 3 AQUILA study showed that subcutaneous daratumumab elicited a significant improvement in PFS ...